ArticleFrontiers in oncology2025

PEComa progressed by mTOR inhibitor therapy with anti-VEGFR TKI combined with PD-1 inhibitor: a case report.

Guannan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.